Results 21 to 30 of about 2,044 (173)

Prevalence of indeterminate tuberculosis interferon‐gamma release assays in COVID‐19 patients: Systematic review and meta‐analysis

open access: yesHealth Science Reports, Volume 6, Issue 12, December 2023., 2023
Abstract Background and Aims The reliability of interferon‐gamma‐release‐assays (IGRAs) for tuberculosis (TB) testing in coronavirus disease 2019 (COVID‐19) patients is unknown. This study aimed to systematically review the prevalence of indeterminate TB‐IGRA following SARS‐CoV‐2 infection or vaccination and to review associated factors.
Aicha Ben Tekaya   +6 more
wiley   +1 more source

Design and development of a multi‐epitope vaccine for the prevention of latent tuberculosis infection

open access: yesMedicine Advances, Volume 1, Issue 4, Page 361-382, December 2023., 2023
Abstract Background Latent tuberculosis infection (LTBI) often progresses to active tuberculosis, necessitating the development of novel vaccine to prevent LTBI. In this study, we aimed to design a Mycobacterium tuberculosis (M. tuberculosis) vaccine that could elicit a potent immune response to prevent LTBI.
Fan Jiang   +5 more
wiley   +1 more source

Longitudinal analysis of QuantiFERON-TB Gold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study. [PDF]

open access: yesPLoS ONE, 2011
QuantiFERON-TB Gold In Tube (QFT-GIT) is a tool for detecting M. tuberculosis infection. However, interpretation and utility of serial QFT-GIT testing of pediatric tuberculosis (TB) contacts is not well understood.
Maunank Shah   +5 more
doaj   +1 more source

Bottlenecks and recent advancements in detecting Mycobacterium tuberculosis in patients with HIV

open access: yesiLABMED, Volume 1, Issue 1, Page 44-57, June 2023., 2023
Tuberculosis (TB) is difficult to diagnose, particulally in HIV‐positive individuals, leading to a delayed disease treatment and poor prognosis. Herein, we summarize the strengths and limitations of current TB diagnostic methods, and shed light on the obstacles of TB diagnosis in people living with HIV.
Zixun Lin   +6 more
wiley   +1 more source

Pulmonary tuberculosis associated acute fibrinous and organizing pneumonia: A case report and literature review

open access: yesThe Clinical Respiratory Journal, Volume 17, Issue 6, Page 499-506, June 2023., 2023
Pulmonary tuberculosis presenting secondary OP and AFOP are rare. We present a case of 44‐year‐old male with AFOP secondary to Mycobacterium tuberculosis and searched existing literature relevant to OP and AFOP caused by tuberculosis. Abstract Background Acute fibrinous and organizing pneumonia (AFOP) is a rare histological interstitial pneumonia ...
Xiang Zhao   +3 more
wiley   +1 more source

A data driven policy to minimise the tuberculosis testing cost among healthcare workers

open access: yesThe International Journal of Health Planning and Management, Volume 37, Issue 5, Page 2697-2709, September 2022., 2022
Abstract Introduction The Centres for Disease Control and Prevention (CDC) mandates that healthcare employees at high‐risk exposure to Tuberculosis (TB) undergo annual testing. Currently, two methods of TB testing are used: a two‐step skin test (TST) or a whole‐blood test (IGRA).
Vishnunarayan Girishan Prabhu   +3 more
wiley   +1 more source

Comparison of diagnostic accuracy of QuantiFERON‐TB Gold Plus and T‐SPOT.TB in the diagnosis of active tuberculosis in febrile patients

open access: yesJournal of Evidence-Based Medicine, Volume 15, Issue 2, Page 97-105, June 2022., 2022
Abstract Objective This study aimed to compare the accuracy of QuantiFERON‐TB Gold Plus (QFT‐Plus) and T‐SPOT.TB for diagnosing active tuberculosis (ATB) in febrile patients, to explore influencing factors of positive results and to verify the potential value of QFT‐Plus in the identification of ATB and latent tuberculosis infection (LTBI).
Lifan Zhang   +8 more
wiley   +1 more source

Testing for Mycobacterium tuberculosis infection using the QuantiFERON-TB GOLD assay in patients with comorbid conditions in a tertiary care endemic setting

open access: yesTropical Diseases, Travel Medicine and Vaccines, 2020
Introduction There were 10 million new cases of tuberculosis (TB) in 2017. To eliminate TB, it is necessary to diagnose active TB and latent tuberculosis infection (LTBI).
Kiran Iqbal Masood   +5 more
doaj   +1 more source

Incidence and Risk of Lung Cancer in Tuberculosis Patients, and Vice Versa: A Literature Review of the Last Decade

open access: yesBioMed Research International, Volume 2022, Issue 1, 2022., 2022
Background. The incidence and risk of both lung cancer (LC) and tuberculosis (TB) are increasing rapidly. These two diseases frequently exist together and can influence the incidence and risk of each other. The aim of the current review was to summarize the incidence and risk of LC in TB patients, and vice versa, short out research gap, and contemplate
Sutapa Bhowmik   +4 more
wiley   +1 more source

A century of BCG: Impact on tuberculosis control and beyond

open access: yesImmunological Reviews, Volume 301, Issue 1, Page 98-121, May 2021., 2021
Abstract BCG turns 100 this year and while it might not be the perfect vaccine, it has certainly contributed significantly towards eradication and prevention of spread of tuberculosis (TB). The search for newer and better vaccines for TB is an ongoing endeavor and latest results from trials of candidate TB vaccines such as M72AS01 look promising ...
Asma Ahmed   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy